Results 151 to 160 of about 50,638 (234)
Herpes zoster reactivation [PDF]
M, Ziaei, S A, Aslam, H, Ziaei
openaire +2 more sources
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang +3 more
wiley +1 more source
Herpes Zoster and Frailty in Older Adults: a Systematic Review. [PDF]
D'Elia MPB, Andrew MK, Pott H.
europepmc +1 more source
Abstract Background Effectively identifying individuals exposed to drug underuse, overuse and potentially inappropriate medication (PIM) in older adults is essential for minimizing preventable drug‐related harms. Methods We analysed data from 54,296 individuals aged 60–74 years from the German National Cohort (NAKO).
Miriam Degen +18 more
wiley +1 more source
Sacral Herpes Zoster Mimicking Pressure Ulcers and Causing Elsberg Syndrome. [PDF]
Yamada J +5 more
europepmc +1 more source
Herpes Zoster of the Larynx: A Diagnostic and Therapeutic Challenge. [PDF]
Nogueira N +4 more
europepmc +1 more source
Epidemiology of herpes zoster at a tertiary care centre in Eastern India. [PDF]
Biswas S +4 more
europepmc +1 more source

